This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Adding troglitazone to glibenclamide in type 2 diabetes: benefits at reasonable cost. Pharmacoecon. Outcomes News 253, 6 (2000). https://doi.org/10.1007/BF03266937
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03266937